(No ratings)
Dr. Jeffrey Dale Hord, MD is a pediatric oncologist in Akron, OH specializing in pediatric hematology, oncology (cancer care) and hematology (blood disorders). He graduated from University of Kentucky College of Medicine. Dr. Jeffrey Dale Hord, MD is affiliated with Akron Children's Hospital and Akron Children's Hospital Cancer and Blood Disorders.
214 West Bowery Street 5th floor Main Hospital Building
Akron, OH 44308
6505 Market Street, Building A Building A Leonard J. Fisher Family Building
Boardman, OH 44512
Dr. Jeffrey Dale Hord, MD graduated from University of Kentucky College of Medicine. He completed residency at Nationwide Children's Hospital. He is certified by the American Board of Pediatrics and has a state license in Ohio.
Medical School: University of Kentucky College of Medicine
Residency: Nationwide Children's Hospital
Board Certification: American Board of Pediatrics
Licensed In: Ohio
Dr. Jeffrey Dale Hord, MD is associated with these hospitals and organizations:
Dr. Jeffrey Dale Hord, MD does not have any reviews yet, be the first to leave a review of Dr. Jeffrey Dale Hord, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Jeffrey Dale Hord, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Biogen Idec Inc. |
$184
PLEGRIDY $72 |
ALPROLIX $42 |
$71 |
---|---|---|---|
Amgen Inc. |
$20
Blincyto $20 |
||
GENZYME CORPORATION |
$17
GAUCHER-DISEASE $17 |
Food and Beverage | $180 |
---|---|
Education | $42 |
Dr. Jeffrey Dale Hord, MD has received 4 research payments totaling $6,575.
Dr. Jeffrey Hord is a pediatric hematology/oncology specialist in Akron, OH, Hudson, OH, and Boardman, OH. In his practice, Dr. Hord focuses on cancer supportive care. He attended the University of Kentucky College of Medicine and then went on to complete his residency at Nationwide Children's Hospital. Dr. Hord is affiliated with Akron Children's Hospital. According to Yext, he is not acceping new patients at this time.